Navigation Links
COR in Medical News

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

... costs. "The recent completion of the cor Phase 3 program was a major milestone for ... co-primary endpoints. Key top-line data from the cor Phase 3 program include the following: ... Key secondary endpoints met in the cor Phase 3 program included significant improvements ...

Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment

... MEDICAL CORP. (NYSE: CMN ), through its Mar cor Purification subsidiary, has continued the ... year. Curt Weitnauer, President of Mar cor Purification, stated, "Adding G.E.M.'s strong ... foundation for a West Coast expansion of the Mar cor service business." Cantel's President and ...

-Contrave(R) Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-

... half of 2010. Key top-line data from the cor Phase 3 program include the following: ... Key secondary endpoints met across the entire cor Phase 3 program included significant improvements ... generally well tolerated by patients across the cor Phase 3 program. ...

Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors

... -- Rcadia Medical Imaging, Ltd., developer of the cor Analyzer(TM) software for the automated analysis ... after a Coronary CTA study, the cor Analayzer(TM) identifies patients who need ... will fund the full commercial launch of the cor Analyzer(TM) and the establishment of a U.S. ...

Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide

... as the population ages. About the Center for Outcomes Research (COR) cor is based at the University of Massachusetts, Worcester, MA, USA. The mission of cor is to collect and evaluate data that reflect real world practices and ...

Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer

... Mr. Kailian was the Chief Executive Officer, President, and a director of cor Therapeutics, Inc. He became the CEO of cor shortly after the company was founded, took the company public in 1991, ...

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain

... with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. In such patients, even usual therapeutic doses ...

Xanodyne Announces Appointment of Mr. Vaughn M. Kailian of MPM Capital to the Board of Directors

... and the New England Healthcare Institute. Mr. Kailian has numerous accomplishments in the pharmaceutical industry including serving as CEO of cor Therapeutics, Inc. (1990-2002) where he took the company public in 1991, raised almost $1 billion in public market capital, and led the $2 billion ...

Conrad A. Conrad Elected Chairman of the Board for Rural/Metro Corporation

... joined the Rural/Metro Board of Directors in October 2005 and has served as a member of both the Audit and Compensation committees. He succeeds Mr. cor Clement, who announced earlier this year he would retire from the Board of Directors at the end of June. "I am honored to serve as Chairman of the ...
COR in Medical Technology

Rcadia's COR Analyzer Family of Products Receives Second FDA Clearance

... Drug Administration (FDA) clearance to market its cor Analyzer family of products, which assists in ... a high negative predictive value (NPV). Rcadia's cor Analyzer system uses proprietary image ... who do not have coronary artery disease. "The cor Analyzer is expected to assist the ED staff in ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. In such patients, even usual therapeutic doses ...

FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain

... with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. Patients receiving other mu-opioid agonist ...

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

... by prolonged bed rest, age over 60, or a previous history of VTE. About cor (Center for Outcomes Research) The Center for Outcomes Research (COR) ... data management and publication development. Established in 1994, cor is an outgrowth of the Worcester Deep Vein Thrombosis Study, a five-year ...
COR in Medical Definition

Pathology

... Angina pectoris - Prinzmetal's angina - Myocardial infarction - Dressler's syndrome Pulmonary circulation Pulmonary embolism - cor pulmonale Pericardium Pericarditis - Cardiac tamponade Endocardium / heart valves Endocarditis - Mitral regurgitation - ...
COR in Medical Dictionary

Cor pulmonale

... cor pulmonale is failure of the right side of the ... Continued Below Right -sided heart failure - cor pulmonale ... cor PULMONALE - Enlargement of the right ...

Congenital Heart Disease

... babies (8 per 1,000). This figure is an underestimate since it does not include some common problems, namely: ... congenital heart disease cor pulmonale pulmonary fibrosis Polycythemia vera Dehydration (such as from severe diarrhea ) Renal ( kidney ) disease with high ...
COR in Biological Technology

Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures

... About the Center for Outcomes Research (COR) cor is based at the University of Massachusetts, Worcester, MA, USA. The mission of cor is to collect and evaluate data that reflect real world practices and ...

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

... acute medical or surgical patients were eligible for the survey. About cor (Center for Outcomes Research) The Center for Outcomes Research (COR) ... data management and publication development. Established in 1994, cor is an outgrowth of the Worcester Deep Vein Thrombosis Study, a five-year ...

Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer

... technology. The firm's investments in life sciences include: ArthroCare, Aspreva Pharmaceuticals Corporation (acquired by Galenica group, SWX: GALN), cor Therapeutics (acquired by Millennium Pharmaceuticals), Corixa (acquired by GlaxoSmithKline, GSK), Coulter Pharmaceutical (acquired by Corixa ...

Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US

... relationships for each measured company, using TNS Healthcare's proprietary TRI*M(TM) Index. R ela t ionship S cor e s Fall e ven f or T o p C o mpanies Even for companies earning high ratings ...

Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors

... the appointment of Roger G. Stoll, Ph.D. to Delcath's Board of Directors. Dr. Stoll is Executive Chairman of Cortex Pharmaceuticals, Inc. (Amex: cor ), a biotechnology company specializing in the treatment of central nervous system disorders. (Logo: ...

MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources

... launch of several ophthalmology and surgical microscopy devices. Prior to Carl Zeiss, Mr. Rosa served as Vice President, Human Resources at cor Therapeutics, Inc., building the development and commercial organizations and launching Integrilin(R) in the cardiovascular angioplasty market. ...

Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer

... at Millennium he was project leader for the US approval and launch of VELCADE(R) and was part of the team that managed the merger of Millennium and cor Therapeutics in 2001. During his period as CEO of Meditech, Ian led the negotiations with Alchemia that resulted in the first merger of two ...
Other Contents
(Date:10/20/2014)... Fort Collins, CO (PRWEB) October 20, 2014 ... platform, dGH assays are the only imaging assays ... data in a single test.  With these three ... in their ability to detect the widest range ... chromosomal translocations—mutations usually missed by other genomic tools, ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Unveiled at the ... Strategic Direction Scorecard conservatively estimates member hospital ROI on membership ... on dues, The Center provides $12.50 in value to member ... (Member Value – Member Dues)/Member Dues. , “This is ... this number and we think the methodology is really sound,” ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher Patronella ... his innovative True Form Tummy Tuck® method ... faculty at The University of Texas Medical Branch ... a medical student. Patronella, who is a founding partner ... practices in Texas, The Aesthetic Center for Plastic ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
Breaking Medicine News(10 mins):Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
(Date:10/15/2014)... to an unexpected extent. The outbreak does not follow ... shows a new disease dynamic in regions, where it ... German National Academy of Sciences Leopoldina, acatech – the ... of the German Academies of Sciences and Humanities have ... In the statement the academies call for the following ...
(Date:10/15/2014)... Rosenstiel Award for Distinguished Work in Biomedical Science by ... of genomic instability and its implications for the immune ... to win the Rosenstiel Award; the first, Rod McKinnon, ... the Charles A. Janeway Professor of Pediatrics and Professor ... at the Howard Hughes Medical Institute at Boston Children,s ...
(Date:10/14/2014)... published in Cancer Research shows SIRT6—a protein ... cancers—can promote the development of skin cancers by turning ... of sun-damaged skin cells. , Previously considered protective, SIRT6 ... sirtuins that help regulate genomic stability and prevent some ... repair DNA damage, which can lead to cancer. This ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
Other TagsOther Tags